Award-linked funding and rank by fiscal year
Fiscal year	Linked awards	Records	Rank
2001	$263,533	1	#16,956
2002	$271,438	1	#18,442
2003	$279,583	1	#19,649
2004	$250,036	1	#23,106
2005	$238,706	1	#24,174
2011	$293,730	1	#26,912
2012	$291,818	1	#27,318
2013	$216,131	1	#30,559
2014	$303,000	1	#25,734
2015	$303,000	1	#25,933
2016	$1,798,253	2	#3,150
2017	$1,799,525	2	#3,131
2018	$1,500,000	1	#4,332
2019	$1,609,059	2	#4,301
2021	$600,085	1	#18,280

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

Publications

A verified OpenAlex publication list is not yet available for this researcher.

Loading publications…

Current affiliation: Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity: Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD: No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage: FY2001 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH award records listing Clemens, Paula R as a PI. Multi-PI records show the full award amount for context.

5R44NS095423-04R44Contact PI
Pivotal trial of vamorolone in Duchenne muscular dystrophy
Reveragen Biopharma, Inc.
$1.5M
award amount
3R44NS095423-03S1R44Contact PI
Establishing a Cost-effective Return of Results to Parents of Boys in VISION-DMD Clinical Trials
Reveragen Biopharma, Inc.
$110K
award amount

Organizations that administered FY2019 awards listing Clemens, Paula R as a PI.

FY2019 award administered by Reveragen Biopharma, Inc. (VA).

Computed from the fiscal years currently available in ScienceDex.

Search NIH-funded principal investigators by topic, department, or activity.

Compare median NIH grant budgets across departments, mechanisms, and years.